These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 8383462)
41. Effects of natriuretic peptides on ventricular myocyte contraction and role of cyclic GMP signaling. Zhang Q; Moalem J; Tse J; Scholz PM; Weiss HR Eur J Pharmacol; 2005 Mar; 510(3):209-15. PubMed ID: 15763244 [TBL] [Abstract][Full Text] [Related]
42. Rat renal preglomerular vessels, glomeruli and papillae do not express detectable quantities of B-type natriuretic peptide receptor. de Leon H; Bonhomme MC; Garcia R J Hypertens; 1994 May; 12(5):539-48. PubMed ID: 7930554 [TBL] [Abstract][Full Text] [Related]
43. Human C-type natriuretic peptide: effects on the haemodynamic and endocrine responses to angiotensin II. Cargill RI; Struthers AD; Lipworth BJ Cardiovasc Res; 1995 Jan; 29(1):108-11. PubMed ID: 7895227 [TBL] [Abstract][Full Text] [Related]
44. Haemodynamic, hormonal and renal actions of osteocrin in normal sheep. Scott NJA; Prickett TCR; Charles CJ; Espiner EA; Richards AM; Rademaker MT Exp Physiol; 2024 Aug; 109(8):1305-1316. PubMed ID: 38890799 [TBL] [Abstract][Full Text] [Related]
45. Presence of functional type B natriuretic peptide receptor in human ocular cells. Pang IH; Shade DL; Matsumoto S; Steely HT; DeSantis L Invest Ophthalmol Vis Sci; 1996 Aug; 37(9):1724-31. PubMed ID: 8759339 [TBL] [Abstract][Full Text] [Related]
46. Role of natriuretic peptides in cGMP production in fetal cardiac bypass. Heeb EA; Baker RS; Lam C; Basu M; Lubbers W; Duffy JY; Eghtesady P Ann Thorac Surg; 2009 Mar; 87(3):841-7. PubMed ID: 19231402 [TBL] [Abstract][Full Text] [Related]
47. Atrial natriuretic peptide and pressure natriuresis: interactions with the renin-angiotensin system. Mizelle HL; Hall JE; Hildebrandt DA Am J Physiol; 1989 Nov; 257(5 Pt 2):R1169-74. PubMed ID: 2531554 [TBL] [Abstract][Full Text] [Related]
48. C-type natriuretic peptide does not affect plasma and urinary adrenomedullin in man. Lazzeri C; Tosti Guerra C; Vecchiarino S; Barletta G; Stefani L; Bandinelli R; Franchi F; La Villa G Clin Physiol; 1999 Jan; 19(1):68-75. PubMed ID: 10068868 [TBL] [Abstract][Full Text] [Related]
49. Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Suga S; Nakao K; Hosoda K; Mukoyama M; Ogawa Y; Shirakami G; Arai H; Saito Y; Kambayashi Y; Inouye K Endocrinology; 1992 Jan; 130(1):229-39. PubMed ID: 1309330 [TBL] [Abstract][Full Text] [Related]
50. Natriuretic peptides as regulatory mediators of secretory activity in the digestive system. Sabbatini ME Regul Pept; 2009 Apr; 154(1-3):5-15. PubMed ID: 19233231 [TBL] [Abstract][Full Text] [Related]
51. Mechanism of the natriuretic action of gamma-melanocyte-stimulating hormone. Chen XW; Ying WZ; Valentin JP; Ling KT; Lin SY; Wiedemann E; Humphreys MH Am J Physiol; 1997 Jun; 272(6 Pt 2):R1946-53. PubMed ID: 9227612 [TBL] [Abstract][Full Text] [Related]
52. Natriuretic peptide system and endothelin in aneurysmal subarachnoid hemorrhage. Wijdicks EF; Schievink WI; Burnett JC J Neurosurg; 1997 Aug; 87(2):275-80. PubMed ID: 9254093 [TBL] [Abstract][Full Text] [Related]
53. Reduced affinity of iodinated forms of Tyr0 C-type natriuretic peptide for rat natriuretic peptide receptor B. Thibault G; Grove KL; Deschepper CF Mol Pharmacol; 1995 Dec; 48(6):1046-53. PubMed ID: 8848004 [TBL] [Abstract][Full Text] [Related]
54. C-type natriuretic peptide stimulates catecholamine synthesis through the accumulation of cyclic GMP in cultured bovine adrenal medullary cells. Tsutsui M; Yanagihara N; Minami K; Kobayashi H; Nakashima Y; Kuroiwa A; Izumi F J Pharmacol Exp Ther; 1994 Feb; 268(2):584-9. PubMed ID: 7906732 [TBL] [Abstract][Full Text] [Related]
55. Atrial, B-type, and C-type natriuretic peptides cause mesenteric vasoconstriction in conscious dogs. Woods RL; Jones MJ Am J Physiol; 1999 May; 276(5):R1443-52. PubMed ID: 10233038 [TBL] [Abstract][Full Text] [Related]
56. Effects of C-type natriuretic peptide on renal vasoconstriction in dogs. Yoshida K; Yamagata T; Tomura Y; Suzuki-Kusaba M; Yoshida M; Hisa H; Satoh S Eur J Pharmacol; 1997 Nov; 338(2):131-4. PubMed ID: 9455994 [TBL] [Abstract][Full Text] [Related]
57. Effects of intravenously administered C-type natriuretic peptide in humans: comparison with atrial natriuretic peptide. Igaki T; Itoh H; Suga SI; Hama N; Ogawa Y; Komatsu Y; Yamashita J; Doi K; Chun TH; Nakao K Hypertens Res; 1998 Mar; 21(1):7-13. PubMed ID: 9582102 [TBL] [Abstract][Full Text] [Related]
58. Presence of C-type natriuretic peptide in cultured human endothelial cells and plasma. Stingo AJ; Clavell AL; Heublein DM; Wei CM; Pittelkow MR; Burnett JC Am J Physiol; 1992 Oct; 263(4 Pt 2):H1318-21. PubMed ID: 1384363 [TBL] [Abstract][Full Text] [Related]
59. Effect of eel ventricular natriuretic peptide on the kidney and cardiovascular system in the dog. Arai M; Goto F; Takei Y Endocr J; 1996 Apr; 43(2):205-10. PubMed ID: 8793337 [TBL] [Abstract][Full Text] [Related]
60. A C type natriuretic peptide is a vasodilator in vivo and in vitro in the common dogfish. Bjenning C; Takei Y; Watanabe TX; Nakajima K; Sakakibara S; Hazon N J Endocrinol; 1992 May; 133(2):R1-4. PubMed ID: 1535362 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]